Abstract
The purpose of the study was to determine the overall risk of a permanent stoma in patients with complicated perianal Crohn’s disease, and to identify risk factors predicting stoma carriage. A total of 102 consecutive patients presented with the first manifestation of complicated perianal Crohn’s disease in our outpatient department between 1992 and 1995. Ninety-seven patients (95%) could be followed up at a median of 16 years after first diagnosis of Crohn’s disease. Patients were sent a standardized questionnaire and patient charts were reviewed with respect to the recurrence of perianal abscesses or fistulas and surgical treatment, including fecal diversion. Factors predictive of permanent stoma carriage were determined by univariate and multivariate analysis. Thirty of 97 patients (31%) with complicated perianal Crohn’s disease eventually required a permanent stoma. The median time from first diagnosis of Crohn’s disease to permanent fecal diversion was 8.5 years (range 0–23 years). Temporary fecal diversion became necessary in 51 of 97 patients (53%), but could be successfully removed in 24 of 51 patients (47%). Increased rates of permanent fecal diversion were observed in 54% of patients with complex perianal fistulas and in 54% of patients with rectovaginal fistulas, as well as in patients that had undergone subtotal colon resection (60%), left-sided colon resection (83%), or rectal resection (92%). An increased risk for permanent stoma carriage was identified by multivariate analysis for complex perianal fistulas (odds ratio [OR] 5; 95% confidence interval [CI] 2–18), temporary fecal diversion (OR 8; 95% CI 2–35), fecal incontinence (OR 21, 95% CI 3–165), or rectal resection (OR 30; 95% CI 3–179). Local drainage, setons, and temporary stoma for deep and complicated fistulas in Crohn’s disease, followed by a rectal advancement flap, may result in closing of the stoma in 47% of the time. The risk of permanent fecal diversion was substantial in patients with complicated perianal Crohn’s disease, with patients requiring a colorectal resection or suffering from fecal incontinence carrying a particularly high risk for permanent fecal diversion. In contrast, patients with perianal Crohn’s disease who required surgery for small bowel disease or a segmental colon resection carried no risk of a permanent stoma.
Similar content being viewed by others
References
Crohn BB, Ginzburg L, Oppenheimer GD. Regional ileitis: A pathologic and clinical entity. JAMA 1932;99:1323–1329.
Price AB, Morson BC. The surgical pathology of Crohn’s disease and ulcerative colitis. Human Pathol 1975;6:7–29.
Johnson OA, Hoskins DW, Todd J, Thorbjarnarson B. Crohn’s disease of the stomach. Gastroenterology 1996;50:571–577.
Gelfand MD, Krone CL. Dysphagia and esophageal ulceration in Crohn’s disease. Gastroenterology 1968;55:510–514.
Dudeney TP. Crohn’s disease of the mouth. Proc R Soc Med 1969;62:1237.
Wolff BG. Crohn’s disease: the role of surgical treatment. Mayo Clin Proc 1986;61:191–195.
Fielding JF. Perianal lesions in Crohn’s disease. J R Coll Surg Edinb 1971;17:32–37.
Lennard-Jones JE, Ritchie JK, Zohrab WJ. Proctocolitis and Crohn’s disease of the colon: A comparison of the clinical course. Gut 1976;17:477–482.
Allan A, Keighley MRB. Management of perianal Crohn’s disease. World J Surg 1988;12:198–202.
Alexander-Williams J. The place of surgery in Crohn’s disease. Gut 1971;12:739.
Buchmann P, Keighley MRB, Allan RN, Thompson H, Alexander-Williamy J. Natural history of perianal Crohn’s disease: Ten year follow up: A plea for conservatism. Am J Surg 1980;140:642–644.
Keighley MRB, Allan RN. Current status and influence of operation on perianal Crohn’s disease. Int J Colorectal Dis 1986;1:104–107.
Alexander-Williams J, Buchmann P. Perianal Crohn’s disease. World J Surg 1980;4:203–208.
Poritz LS, Rowe WA, Koltun WA. Remicade does not abolish the need for surgery in fistulizing Crohn’s disease. Dis Colon Rectum 2002;45:771–775.
Dejaco C, Harrer M, Waldhoer T, Miehsler W, Vogelsang H, Reinisch W. Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn’s disease. Aliment Pharmacol Ther 2003;18:1113–1120.
Oberhelman HA, Kohatsu S, Taylor KB, Kivel RM. Diverting ileostomy in the surgical management of anal and perianal Crohn’s disease of the colon. Am J Surg 1968;115:231–240.
Burman JM, Thompson M, Cooke WT, Alexander-Williams J. The effects of diversion of intestinal contents on the progress of Crohn’s disease of the large bowel. Gut 1971;2:11.
Frizelle FA, Santoro GA, Pemberton JH. The management of perianal Crohn’s disease. Int J Colorectal Dis 1996;11:227–237.
McClane, Rombeau JL. Anorectal Crohn’s disease. Surg Clin North Am 2001;81:169–183.
Parks AG, Gordon PH, Hardcastle JD. A classification of fistula-in-ano. Br J Surg 1976;63:1–12.
Makowiec F, Jehle EC, Starlinger M. Clinical course of perianal fistulas in Crohn’s disease. Gut 1995;37:696–701.
Makowiec F, Jehle EC, Becker HD, Starlinger M. Perianal abscess in Crohn’s disease. Dis Colon Rectum 1997;40:443–450.
Makowiec F, Jehle EC, Becker HD, Starlinger M. Clinical course after transanal advancement flap repair of perianal fistula in patients with Crohn’s disease. Br J Surg 1995;82:603–606.
Williams DR, Collier JA, Corman ML, Nugent FW, Veidenheimer MC. Anal complications in Crohn’s disease. Dis Colon Rectum 1981;24:22–24.
Williamson PR, Hellinger MD, Larach SW, Ferrara A. Twenty-year review of the surgical management of perianal Crohn’s disease. Dis Colon Rectum 1995;38:389–392.
Williams JG, Rothenberger DA, Nemer FD, Goldberg SM. Fistula-in-ano in Crohn’s disease: Results of aggressive surgical treatment. Dis Colon Rectum 1991;34:378–384.
Sohn N, Korelitz BI, Weinstein MA. Anorectal Crohn’s disease: Definitive surgery for fistulas and recurrent abscesses. Am J Surg 1980;139:394–397.
Bernard D, Morgan S, Tasse D. Selective surgical management of Crohn’s disease of the anus. Can J Surg 1986;29:318–321.
Scott HJ, Northover JMA. Evaluation of surgery for perianal Crohn’s disease. Dis Colon Rectum 1996;39:1039–1043.
Present DH, Rutgeerts P, Targan S, et al. Infliximab for the treatment of fistulas in patients with Crohn’s disease. N Engl J Med 1999;340:1398–1405.
Van Assche G, Vanbeckevoort D, Bielen D, Coremans G, Aerden I, Noman M, D’Hoore A, Penninckx F, Marchal g, Cornillie F, Rutgeerts P. Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn’s disease. Am J Gastroenterol 2003;98:332–339.
Hyman N. Endoanal advancement flap repair for complex anorectal fistulas. Am J Surg 1999;178:337–340.
Radcliffe AG, Ritchie JK, Hawely PR, Lennard-Jones JE, Northover JMA. Anovaginal and rectovaginal fistulas in Crohn’s disease. Dis Colon Rectum 1988;31:94–99.
Mizrahi N, Wexner SD, Zmora O, Da Silva G, Efron J, Weiss EG, Vernava AM, Nogueras JJ. Endorectal advancement flaps. Are there predictors of failure? Dis Colon Rectum 2002;45:1616–1621.
Keighley MR, Williams NS. Surgical treatment of perianal Crohn’s disease. In Keighley MR, Williams NS, Eds. Surgery of the Anus, Rectum, and Colon, 2nd ed. New York: WB Saunders, 1999, pp 2135.
Sonoda T, Hull T, Piedmonte MR, Fazio VW. Outcomes of primary repair of anorectal and rectovaginal fistulas using the endorectal advancement flap. Dis Colon Rectum 2002;45:1622–1628.
Hull TL, Fazio VW. Surgical approaches to low anovaginal fistulas in Crohn’s disease. Am J Surg 1997;173:95–98.
Halverson AL, Hull TL, Fazio VW, Church J, Hammel J, Floruta C. Repair of recurrent rectovaginal fistulas. Surgery 2001:30:753–758.
Korelitz BI, Present DH. Favorable effect of 6-mercaptopurine on fistulae in Crohn’s disease. Dig Dis Sci 1985;30:58–64.
Pearson DC, May GR, Fick GH, Sutherland LR. Azathioprine and 6-mercaptopurine in Crohn’s disease: A meta-analysis. Ann Intern Med 1995;123:132–142.
Weiss UL, Jehle E, Becker HD, Buess GF, Starlinger M. Laparoscopic ileostomy. Br J Surg 1995;82:1648.
Scott HJ, Northover JMA. Evaluation of surgery for perianal Crohn’s fistulas. Dis Colon Rectum 1996;39:1039–1043.
Andersson P, Olaison G, Bendtsen P, Myrelid P, Sjödahl R. Health related quality of life in Crohn’s proctocolitis does not differ from a general population when in remission. Colorectal Dis 2003;5:56–62.
Post S, Herfarth C, Schumacher H, Golling M, Schürmann G, Timmermanns G. Experience with ileostomy and colostomy in Crohn’s disease. Br J Surg 1995;82:1629–1633.
Hurst RD, Molinari M, Chung TP, Rubin M, Michelassi F. Prospective study of the features, indications, and surgical treatment in 513 consecutive patients affected by Crohn’s disease. Surgery 1997;122:661–668.
Harper PH, Kettlewell MGW, Lee ECG. The effect of split ileostomy on perianal Crohn’s disease. Br J Surg 1982;69:608–610.
Edwards CM, George BD, Jewell DP, Warren BF, Mc Mortensen NJ, Kettlewell MGW. Role of a defunctioning stoma in the management of large bowel Crohn’s disease. Br J Surg 2000;87:1063–1066.
Yamamoto T, Allan RN, Keighley MRB. Effect of fecal diversion alone on perianal Crohn’s disease. World J Surg 2000;24:1258–1263.
Pescatori M, Interisano A, Basso L, Arcana F, Buffatti P, Di Bella F, Doldi A, Forcheri V, Gaetini R, Pera A, Mattana C, Prantera C, Pulvirenti A, Segre D, Simi M, Tonelli F.. Management of perianal Crohn’s disease. Results of a multicenter study in Italy. Dis Colon Rectum 1995;38:121–124.
Bell SJ, Williams AB, Wiesel P, Wilkinson K, Cohen RCG, Kamm MA. The clinical course of fistulating Crohn’s disease. Aliment Pharmacol Ther 2003;17:1145–1151.
Andersson P, Olaison G, Bodemar G, Nyström P-O, Sjödahl R. Surgery for Crohn colitis over a twenty-eight-year period: Fewer stomas and the replacement of total colectomy by segmental resection. Scand J Gastroenterol 2002;37:68–73.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mueller, M.H., Geis, M., Glatzle, J. et al. Risk of Fecal Diversion in Complicated Perianal Crohn’s Disease. J Gastrointest Surg 11, 529–537 (2007). https://doi.org/10.1007/s11605-006-0029-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-006-0029-3